Hamilton Medical obtains favorable decision from U.S. Patent and Trademark Office in patent challenge

The case stems from a claim made by Dr. Fleur Tehrani that the INTELLiVENT-ASV (Not available in the US and some other marketsA​) ventilator control systems from Hamilton Medical infringe certain claims of Tehrani’s US ‘571 patent. In its final written decision issued on December 28, 2021, the U.S. Patent and Trademark Office Patent and Appeal Board held that all patent claims of the Tehrani US ‘571 patent challenged by Hamilton are “unpatentable.”

This decision clears the way for Hamilton to proceed with pending FDA approval of INTELLiVENT-ASV for entry into the US market.

Hamilton Technologies LLC v. Fleur Tehrani, P.T.A.B., No. IPR2020-01199, 12/28/21